Rapid removal of vancomycin by continuous veno-venous hemofiltration

被引:6
|
作者
Shah, M [1 ]
Quigley, R [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75237 USA
关键词
vancomycin; acute renal failure; continuous veno-venous hemofiltration nephrotoxicity;
D O I
10.1007/s004670000317
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We describe a 14-year-old girl with staphylococcal (coagulase-negative) ventriculo-peritoneal shunt infection, who developed oliguric acute renal failure and was found to have a serum vancomycin concentration of 250 mu g/ml. Since only about 10%-50% of vancomycin is bound to protein in blood, we employed continuous veno-venous hemofiltration (CVVH) with a high ultrafiltration rate (1,800 ml/h) for increased convective clearance to remove vancomycin, which may have contributed to the acute renal failure. At the end of 38 h of CVVH, the vancomycin concentration had decreased in an exponential manner to 27 mu g/ml. Over the subsequent 3-4 days, her renal function improved and the vancomycin concentration decreased further to <5 mu g/ml. In conclusion, we believe that a high serum vancomycin concentration may be nephrotoxic and demonstrate that CVVH can be used effectively to remove vancomycin in children with acute renal failure.
引用
收藏
页码:912 / 915
页数:4
相关论文
共 50 条
  • [41] Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock
    Schusterschitz, N.
    Bellmann, R.
    Stein, M.
    Dunzendorfer, S.
    Pechlaner, C.
    Joannidis, M.
    INTENSIVE CARE MEDICINE, 2008, 34 (07) : 1350 - 1351
  • [42] Continuous veno-venous hemodiafiltration or hemofiltration: Impact on calcium, phosphate and magnesium concentrations
    Morimatsu, H
    Uchino, S
    Bellomo, R
    Ronco, C
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (06): : 512 - 519
  • [43] THERAPEUTIC VALUE OF CONTINUOUS VENO-VENOUS HEMOFILTRATION ADMINISTRATION IN TREATING FULMINANT MYOCARDITIS
    Ma, Min
    Hui, Jie
    Lv, Baining
    Meng, Yanqiu
    HEART, 2011, 97 : A209 - A209
  • [44] MECCIAS trial: Metabolic consequences of continuous veno-venous hemofiltration on indirect calorimetry
    Jonckheer, J.
    Demol, J.
    Lanckmans, K.
    Malbrain, M. L. N. G.
    Spapen, H.
    De Waele, E.
    CLINICAL NUTRITION, 2020, 39 (12) : 3797 - 3803
  • [45] Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole
    Muhl, E
    Martens, T
    Iven, H
    Rob, P
    Bruch, HP
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (9-10) : 671 - 678
  • [46] PHARMACOKINETICS OF CASPOFUNGIN IN CRITICALLY ILL PATIENTS DURING CONTINUOUS VENO-VENOUS HEMOFILTRATION
    Weiler, S.
    Seger, C.
    Pfisterer, H.
    Stippler, F.
    Griesmacher, A.
    Joannidis, M.
    Bellmann, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 42 - 42
  • [47] Assessment of acetate free continuous veno-venous hemofiltration in acute renal failure
    Wynckel, A
    Wuillai, A
    Bene, B
    Cornillet, J
    Randoux, C
    Chanard, J
    ASAIO JOURNAL, 1998, 44 (05) : M606 - M609
  • [48] Assessment of acetate free continuous veno-venous hemofiltration in acute renal failure
    Wynckel, Alain
    Wuillai, Anne
    Bene, Bernard
    Cornillet, Josiane
    Randoux, Christine
    Chanard, Jacques
    ASAIO Journal, 44 (05):
  • [49] Regional citrate anticoagulation in continuous veno-venous hemofiltration using commercial preparations
    Munjal, Sandeep
    Ejaz, A. Ahsan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 245 - 245
  • [50] Continuous veno-venous hemofiltration without anticoagulation in high-risk patients
    Tan, HK
    Baldwin, I
    Bellomo, R
    INTENSIVE CARE MEDICINE, 2000, 26 (11) : 1652 - 1657